Jacobs Levy Equity Management, Inc Biogen Inc. Transaction History

Jacobs Levy Equity Management, Inc

$24.2 Billion
Q2 2025

A detailed history of Jacobs Levy Equity Management, Inc transactions in Biogen Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 12,625 shares of BIIB stock, worth $1.85 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

12,625

Previous 61,393 79.44%

Holding current value

$1.85 Million

Previous $8.4 Million 81.13%

% of portfolio

0.01%

Previous 0.04%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$113.38 - $135.49 $5.53 Million - $6.61 Million	-48,768 Reduced 79.44%	12,625 $1.59 Million
Q1 2025 May 15, 2025	BUY	$133.43 - $153.27 $8.19 Million - $9.41 Million	61,393 New	61,393 $8.4 Million
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $307,706 - $387,694	-1,588 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $355,584 - $456,978	1,588 New	1,588 $381,000
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $44.2 Million - $70.8 Million	-170,620 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $36 Million - $42.1 Million	148,024 Added 655.09%	170,620 $47.7 Million
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $33,312 - $50,143	-141 Reduced 0.62%	22,596 $5.53 Million
Q3 2020 Nov 16, 2020	BUY	$264.77 - $305.71 $5.44 Million - $6.29 Million	20,562 Added 945.38%	22,737 $6.45 Million
Q2 2020 Aug 17, 2020	SELL	$258.66 - $342.55 $76.9 Million - $102 Million	-297,145 Reduced 99.27%	2,175 $582,000
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $15.9 Million - $20.1 Million	-58,993 Reduced 16.46%	299,320 $94.7 Million
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $10.9 Million - $15 Million	49,474 Added 16.02%	358,313 $106 Million
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $28.9 Million - $32.4 Million	133,022 Added 75.66%	308,839 $71.9 Million
Q2 2019 Aug 13, 2019	BUY	$219.29 - $241.72 $38.6 Million - $42.5 Million	175,817 New	175,817 $41.1 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $508,359 - $664,793	-1,732 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $8.08 Million - $9.63 Million	-31,392 Reduced 94.77%	1,732 $503,000
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $6.07 Million - $8.59 Million	23,350 Added 238.9%	33,124 $9.07 Million
Q4 2017 Feb 13, 2018	SELL	$307.64 - $344.58 $1.45 Million - $1.63 Million	-4,722 Reduced 32.57%	9,774 $3.11 Million
Q3 2017 Nov 14, 2017	SELL	$281.15 - $329.69 $4.1 Million - $4.81 Million	-14,583 Reduced 50.15%	14,496 $4.54 Million
Q2 2017 Nov 09, 2017	BUY	N/A	29,079	29,079 $7.89 Million

Others Institutions Holding BIIB

# of Institutions

1,024

Shares Held

131M

Call Options Held

2.87M

Put Options Held

2.57M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Account

Jacobs Levy Equity Management, Inc Biogen Inc. Transaction History